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Abstract  
 
Drymaria cordata (Linn.) Willd (Caryophyllaceae) is an herbaceous plant widely used in traditional African medicine 
(TAM) for the treatment of diverse ailments including painful and febrile conditions. This study was conducted to investigate the 
analgesic and antipyretic properties of the whole plant extract of D. cordata. The acetic acid-induced writhing, formalin, and tail 
clip tests were used to evaluate analgesic activity while the 2,4-dinitrophenol (DNP)-, d-amphetamine-, and yeast-induced 
hyperthermia tests were used to investigate antipyretic activity in rodents. D. cordata (100, 200, and 400 mg kg-1, p.o) produced 
significant (p<0.05) analgesic activity in the mouse writhing, formalin (second phase), and tail clip tests. The effects of D. cordata 
were generally comparable to those of acetylsalicylic acid (ASA, 100 mg kg-1, p.o) and morphine (2 mg kg-1, s.c). Also, D. 
cordata produced significant (p<0.05) dose-dependent inhibition of temperature elevation in the 2,4-DNP and yeast-induced 
hyperthermia models with peak effects produced at the dose of 400 mg kg-1. The effect at this dose was comparable to that of 
ASA in the two models. In the d-amphetamine method, D. cordata produced significant (p<0.05) dose- and time-dependent 
reduction of temperature elevation with peak effect produced at the dose of 200 mg kg-1. The effect of the extract at this dose was 
greater than that of ASA. The results obtained in this study demonstrate that the aqueous whole plant extract of Drymaria cordata 
possesses analgesic and antipyretic properties mediated through peripheral and central mechanisms.    
 
Keywords: Drymaria cordata, Caryophyllaceae, analgesic activity, antipyretic activity, traditional African medicine (TAM)       
 
 
 
Introduction     
 
Over the years, plants have generally proven to be veritable sources of drugs used in orthodox medicine. This has in 
recent times encouraged the search for newer more efficacious and better tolerated drugs from plants. A criterion that has been 
used over the years for the selection of plants for pharmacological investigations is reported use in traditional medicine. Drymaria 
cordata (Linn.) Willd (Caryophyllaceae) is  a  weak  spreading  herb  found  widely  dispersed  in damp  places  all  over  the  
tropics  of Africa,  Asia  and the Americas (Burkill, 1985). The plant appears spontaneously  as  a  weed  of  cultivation,  with  
stems growing to  nearly  one  meter  long and leaves being rounded,  heart-shaped  and  hairless. It is  usually  found  occupying  
grassland,  forest  margins,  roadsides  and  cultivated  areas, often  under  shade at mid  to  higher  elevations.  The  use  of  the  
plant  for agriculture  and  traditional  medicine  has  been  reported  in Africa,  Asia  and the Americas (Burkill,  1985). In 
tropical Africa, D. cordata preparations are used for the treatment of diverse ailments including cold, headache, coryza, 
bronchitis, as poultice on sore (to treat aching, inflamed or painful parts), leprosy, tumors, as fumigant for eye troubles, as 
cerebral stimulant and antifebrile agent (Burkill, 1985). Extracts of D. cordata have previously been reported to possess 
antitussive (Mukherjee et al., 1997), anti-inflammatory (Adeyemi et al., 2008), anxiolytic (Barua et al., 2009), and cytotoxic 
(Sowemimo et al., 2009) activities.                         
 In  Nigeria, D. cordata (chick weed; “Calabar woman’s eye”) is used  in folk  medicine  to  treat sleeping disorders, 
convulsions, and  febrile  conditions  in  children (Adeyemi et al., 2008). The aim of this study is to investigate the analgesic and 
antipyretic activities of the aqueous whole plant extract of D. cordata in rodents using different pharmacological models.                  
 
 
 
Materials and methods      
Plant material and preparation of plant extract   
 
Drymaria cordata plant (Figure 1) was obtained from a local farmland in Ibadan, Oyo State, Nigeria, in the month of 
June 2008. Botanical identification and authentication was done by Prof. J.D. Olowokudejo of the Department of Botany and 
Microbiology, Faculty of Science, University of Lagos, Lagos, Nigeria and Mr.  T.  K.  Odewo, Senior Superintendent of the  
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Figure 1: Drymaria cordata 
 
 
Forestry Research Institute of Nigeria (FRIN), Ibadan, Nigeria. The voucher specimen of the plant was deposited at the herbarium 
of the Institute and it was assigned reference number FHI 105715.  Fresh D. cordata plant was separated from extraneous 
materials and washed. Sixty five grams of the whole plant was pounded using mortar and pestle, and macerated in distilled water 
(10 g in 1 L). This was kept at 4 0C in the refrigerator for 48 h. The filtrate was decanted and evaporated to dryness in an oven 
(Griffin 2/250 FC) set at 40 0C, giving a percentage yield of 14.68 %. The dried extract was weighed using a Mettler-Toledo 
GmbH digital weighing balance (Type BD202, SNR 06653) and dissolved in distilled water to give a concentration of 100 mg/ml 
before administration to experimental animals. The plant extract was prepared in this way based on the form in which it is used 
traditionally.        
 Yield (%) = (Weight of dried extract ÷ Weight of plant starting material) × 100.       
 
Laboratory animals    
 
Adult  albino mice (20 – 25 g) and rats (100 – 200 g) of either sex used in this study were in-bred and obtained from the  
Laboratory  Animal  Centre  of  the College of  Medicine,  University  of  Lagos, Lagos, Nigeria. The animals were maintained 
under standard environmental conditions and fed with standard diet (Livestock Feeds PLC, Lagos, Nigeria) and water ad libitum. 
The experimental procedures used in this study were in strict compliance with the United States National Institutes of Health 
Guidelines for Care and Use of Laboratory Animals in Biomedical Research (1985).          
 
Drugs and chemicals     
 
Acetic acid (BDH Chemicals Ltd., Poole, England); formalin (UNIC Pharmaceuticals, Lagos, Nigeria); acetylsalicylic 
acid, ASA (Dispirin®; Reckitt & Coleman Ltd., Pakistan); morphine (Evans Medical Ltd., Leatherhead, England); amphetamine 
(BDH, Poole England); Yeast (Kunimed Pharmachem Ltd., Lagos, Nigeria); methylcellulose (Koch-Light Laboratories Ltd., 
Suffolk, England); 2,4-Dinitrophenol (DNP); and sodium chloride (May and Baker, Nigeria PLC).             
 
Phytochemical screening    
 
Qualitative and quantitative analysis of the aqueous whole plant extract of D. cordata was carried out using standard 
procedures (Sofowora, 1993; Edeoga et al., 2005).              
  
Pharmacological studies   
Analgesic activity: Mouse writhing test   
 
Adult mice fasted overnight were divided into six groups of five animals each. Treatment was then carried out 
accordingly: saline (10 ml kg-1, p.o); D. cordata (100, 200, and 400 mg kg-1, p.o); ASA (100 mg kg-1, p.o); and morphine (2 mg 
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kg-1, s.c). sixty minutes post-treatment for oral route or 30 min. post-treatment for subcutaneous route, mice were given acetic 
acid (0.6% v/v in saline, 10 ml kg-1, i.p). The number of writhes (characterized by contraction of the abdominal musculature and 
extension of the hind limbs) was then counted at 5 min. interval for 30 min. (Singh and Majumdar, 1995; Mbagwu et al., 2007).  
 Inhibition (%) = Number of Writhes [Control] – Number of Writhes [Treatment] ×100  
                                                       Number of Writhes [Control]     
 
Formalin test    
 
Adult mice fasted overnight were divided into 6 groups of 6 animals each. Treatment was then carried out as scheduled: 
saline (10 ml kg-1, p.o); D. cordata (100, 200 and 400 mg kg-1, p.o); ASA (100 mg kg-1, p.o); and morphine (2 mg kg-1, s.c). Sixty 
minutes post-treatment for oral route or 30 min. post-treatment for subcutaneous route, formalin (20 µL of 1 % solution) was 
injected s.c into the right hind paw. The time (s) spent in licking and biting responses of the injected paw was taken as an 
indicator of pain response. Responses were measured for 5 min. after formalin injection (first phase) and 15-30 min. after 
formalin injection (second phase) (Shibata et al., 1989; Mbagwu et al., 2007).      
 Inhibition (%) = Reaction Time [Control] – Reaction Time [Treatment] × 100  
                                                       Reaction Time [Control]   
 
Tail clip test    
 
Mice used in this experiment were initially screened by applying a metal artery clip to the root of the mouse’s tail to 
induce pain. Animals which failed to attempt to dislodge the clip in 10 s were discarded. After selecting mice that qualify for the 
experiment, animals were divided into groups as outlined in the formalin test. The initial reaction time of all mice to the tail clip 
was determined after which treatment was carried out as stated in the formalin test. The reaction time of each mouse was then 
determined at 30 min. interval for 3 h (Adeyemi et al., 2004). A post-treatment cut-off time of 30 s was observed.        
 % Inhibition = [Post -treatment Latency] – [Pre-treatment Latency] × 100  
                                    [Cut-off Time – Pre-treatment Latency] 
 
Antipyretic activity  
2,4-DNP-induced hyperthermia        
 
The basal oral temperature of rats fasted for 12 h was recorded (To 0C). Pyrexia was then induced by intraperitoneal 
injection of 2,4-DNP (prepared at a concentration of 1 mg/ml in 0.9 % sodium chloride solution) at a dose of 20 mg kg-1 (Berkan 
et al., 1991). After the confirmation of hyperthermia 30 min. after 2,4-DNP administration, treatment was then carried out orally 
in five groups of six animals each as outlined: distilled water (10 ml kg-1), D. cordata extract (100, 200 and 400 mg kg-1) and 
aspirin (100 mg kg-1). The oral temperature of rats was then recorded at 1, 2, 3 and 4 h post-treatment (Tx 0C).             
 
Amphetamine-induced hyperthermia    
 
The  basal  oral  temperatures  of  rats  fasted  for  12 h  were  recorded  (To 0C) prior  to  the  induction  of  pyrexia  by 
intraperitoneal injection  of  d-amphetamine 10 mg/kg (Berkan et al., 1991). After confirmation of hyperthermia in the 
experimental animals 30 min. after  d-amphetamine  administration,  treatment  was  carried  out  in  five  groups  of  six animals  
each via the oral route;   distilled water (10 ml kg-1), D. cordata extract (100, 200 and  400 mg kg-1)  and  aspirin  (100 mg kg-1). 
The  oral  temperatures of  the  animals  were  then  recorded  1,  2,  3,  4 h post-treatment (Tx 0C).        
 
Yeast-induced hyperthermia      
 
This was carried out based on the method described by Mukherjee et al. (2002). Rats were randomly divided into five 
groups of six rats each. The basal  oral temperatures  of  the animals were recorded (To 0C) over  a period  of  one  hour and the  
average  basal oral temperature  of  each animal  was  recorded. Ten ml kg-1 of yeast suspension (15 % in 0.5 % w/v 
methylcellulose) was injected subcutaneously into the rats to induce pyrexia. Nineteen hours after yeast injection, the oral 
temperatures of animals were taken and animals showing rises in temperature of less than 0.6 0C were discarded (Murkherjee et 
al., 2002). After the establishment of pyrexia, distilled water (10 ml kg-1), D. cordata extract (100, 200, and 400 mg kg-1) and 
aspirin (100 mg kg-1) were orally administered to qualified rats. The oral temperatures of animals were then recorded at 1, 2, 3, 
and 4 h post-treatment (Tx 0C).         
 Inhibition (%) = [Tx 0C -  To 0C Control] - [Tx 0C -  To 0C Treatment]    
                                              [Tx 0C - To 0C Control]         
 
Effect of D. cordata on normal body temperature    
 
The basal oral temperature of rats fasted for 12 h was recorded (To 0C). Treatment was then carried out in five groups of 
four animals each as detailed below: distilled water (10 ml kg-1, p.o), D. cordata extract (100, 200 and 400 mg kg-1, p.o) and 
aspirin (100 mg kg-1, p.o). The oral temperature of rats was then recorded at 1, 2, 3 and 4 h after treatment.       
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Statistical analysis 
 
Results obtained were expressed as mean ± SEM. The data were analyzed using one way ANOVA followed by Tukey’s 
multiple comparison test using GraphPad Prism 5 (GraphPad Software Inc., CA, USA). Results were considered significant when 
p<0.05.             
 
 
 
Results     
 
Qualitative and quantitative assessment of the aqueous whole plant extract of D. cordata revealed the presence of 
glycosides, saponins (0.85 %), alkaloids (1.42 %), flavonoids (1.49 %), Phenols (1.96 %), and tannins (20.61 %).       
 Intraperitoneal injection of acetic acid elicited the writhing reflex in control animals with the total number of writhes in 
30 min. being 79.60 ± 3.67. D. cordata at the most effective dose, 200 mg kg-1, produced significant (p<0.05) reduction in the 
number of writhes (49.00 ± 9.63; 38.44 % inhibition) relative to control. Both ASA (100 mg kg-1) and morphine (2 mg kg-1) also 
significantly (p<0.01, 0.001) reduced the number of writhes relative to control giving values of 35.80 ± 4.16 (55.03 % inhibition) 
and 1.80 ± 0.80 (97.74 % inhibition), respectively. The effect of D. cordata at the dose of 200 mg kg-1 was not significantly 
different (p>0.05) from that of ASA but was significantly less (p<0.001) than that of morphine (Figure 2). In respect of time 
course of elicitation of the writhing reflex, the greatest number of writhes was generally produced at the 5-10 min. interval (Figure 
3).          
 As shown in Figure 4, D. cordata extract (100-400 mg kg-1) and ASA (100 mg kg-1) did not produce any significant 
(p>0.05) effect on the duration of biting and licking responses induced by formalin injection into the hind paw of mice in the first 
phase (0-5 min.) of the formalin test. The effect of morphine (2 mg kg-1) was however significant (p<0.05), reducing the response 
duration from 171.67 ± 36.34 s in control animals to 52.83 ± 21.63 s (69.23 % inhibition). In the second phase of the formalin 
test, peak effect for D. cordata was produced at the dose of 100 mg kg-1 with the reduction of the response duration from 434.83 ± 
28.38 s to 136.67 ± 20.89 s (68.57 % inhibition). Acetylsalicylic acid and morphine also produced significant (p<0.001) effects 
giving response duration values of 282.17 ± 19.49 s (35.11 % inhibition) and 37.67 ± 16.42 s (91.34 % inhibition) respectively, 
compared to control. The effect of morphine was significantly (p<0.001) greater than that of ASA. The effect of D. cordata at the 
most effective dose, 100 mg kg-1, was significantly greater than that of ASA (p<0.001) and less than that of morphine (p<0.01).          
 Comparing the reaction time of tail clip removal attempt pre-treatment and post-treatment, the effect of D. cordata was 
significant (p<0.05, 0.01) only at the post-treatment time of 180 min. at doses of 100 and 400 mg kg-1 with the reaction time 
increased from 4.84 ± 1.31 s in control animals to 18.95 ± 4.33 s and 20.66 ± 5.91 s, respectively. The effect of ASA (100 mg kg-
1; 35.97 %) was not significant (p>0.05) at this post-treatment time but the effect of morphine (2 mg kg-1), which increased the 
reaction time to 17.83 ± 5.52 s; 51.63 %, was significant (p<0.05). The effect of D. cordata at the most effective dose (400 mg kg-
1; 62.88 % inhibition) was greater but not significantly different (p>0.05) from that of morphine (51.63 %). At post-treatment 
times of 30-90 min., morphine produced 100 % inhibition (maximum effect) which reduced to 51.63 % at 180 min (Figure 5).                           
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Figure 2: Effect of D. cordata in the acetic acid-induced mouse writhing test. Data are mean ± SEM (n = 5). αp<0.05, βp<0.01, 
γp<0.001 vs. control; bp<0.01, cp<0.001 vs. D. cordata 100 mg kg-1; 3p<0.001 vs. D. cordata 200 mg kg-1; ***p<0.001 vs. D. 
cordata 400 mg/kg; ●p<0.05 vs. ASA 100 mg kg-1 (one way ANOVA followed by Tukey’s multiple comparison test).          
 
 
 
Akindele et al.,  Afr J Tradit Complement Altern Med. (2012) 9(1):25‐35 
http://dx.doi.org/10.4314/ajtcam.v9i1.4 
29
0 5 10 15 20 25 30
0
5
10
15
20
25
CT
DC 100 mg kg-1
DC 200 mg kg-1
DC 400 mg kg-1
ASA 100 mg kg-1
Morphine 2 mg kg-1
Time (min.)
N
um
be
r 
of
 w
ri
th
es
 
Figure 3: Time course of elicitation of writhing in acetic acid-pain test in mice; data are mean ± SEM (n = 5).     
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Figure 4: Effect of D. cordata in the formalin test in mice. Data are mean ± SEM (n = 6). αp<0.05, γp<0.001 vs. control; bp<0.01, 
cp<0.001 vs. D. cordata 100 mg kg-1; 1p<0.05, 3p<0.001 vs. D. cordata 200 mg kg-1; **p<0.01, ***p<0.001 vs. D. 
cordata 400 mg kg-1; ●●●p<0.001 vs. ASA 100 mg kg-1 (one way ANOVA followed by Tukey’s multiple comparison 
test).                                       
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Figure 5: Effect of D. cordata in the tail clip test in mice. Data are mean ± SEM (n = 6). αp<0.05, βp<0.01, γp<0.001 vs. pre-
treatment time, 0 min. (one way ANOVA followed by Tukey’s multiple comparison test).                            
 
 
Intraperitoneal injection of 2,4-DNP caused an increase in body temperature of control rats from 37.73 0C to 38.65 0C 
(Δ 0.92 0C) 0.5 h after administration. D. cordata (100, 200 and 400 mg kg-1) produced dose-dependent and significant (p<0.01, 
0.001) inhibition of temperature elevation with peak effect produced at 4 h post-treatment with inhibition values of 90.60 %, 
95.70 % and 104.30 %, respectively. At this time interval, the inhibition value obtained for the standard drug (107.20 %), aspirin 
(100 mg kg-1), was comparable and not significantly different from the value for the extract at the dose of 400 mg kg-1 (Table 1). 
Significant inhibition of temperature elevation by the extract was observed from 1 h post-treatment, 65.00 % being the highest at 
the dose of 400 mg kg-1.      
 The administration of amphetamine intraperitoneally caused an increase in the body temperature of control rats from the 
baseline value of 35.77 0C to 38.18 0C (Δ 2.41 0C) 0.5 h after administration. D. cordata (100, 200 and 400 mg kg-1) extract 
produced significant (p<0.05, 0.001) dose- and time-dependent reduction of temperature elevation.  Peak effect (122.00 %) was 
observed at 3 h post-treatment with the dose of 200 mg kg-1. This effect was greater than that elicited by aspirin (86.90 %). As 
early as 1 h post-treatment, the extract produced significant inhibition of pyrexia with the highest value being 76.90 % at 200 mg 
kg-1 (Table 2). On administration of amphetamine, rats manifested increased alertness, aggressiveness and locomotor activity. 
They also showed stereotyped behaviors which consisted of repeated actions like licking, gnawing and rearing.        
 As shown in Table 3, subcutaneous injection of yeast caused elevation of the body temperature in control rats from 
36.87 0C to 38.4 0C (Δ 1.53 0C) 19 h after administration. D. cordata (100, 200 and 400 mg kg-1) produced inhibition of 
temperature elevation with effect being most pronounced (83.60 %) and significant (p<0.05) at the dose of 400 mg kg-1 23 h post-
treatment. This effect was comparable and not significantly different from that produced by aspirin (86.70 %).      
As shown in Table 4, the effect of D. cordata on normal body temperature of rats was only significant (p<0.05) at the 
dose of 400 mg kg-1 at 1 h post-treatment. At this dose and time interval, basal body temperature of rats was reduced from 38.28 
0C to 36.85 0C (Δ 1.43 0C).        
 
 
 
Discussion       
 
In the evaluation of medicinal plants and herbal products for analgesic activity and in the search for newer more 
efficacious and better tolerated pure analgesic compounds, various pharmacological methods of pain evaluation have been used. 
Apart from helping to determine presence or absence of analgesic activity, the various models help to elucidate the mechanism of 
action of active medicinal plants, herbal products, and pure compounds. In this study, the mouse writhing, formalin, and tail clip 
tests have been used to screen for analgesic activity of D. cordata extract.    
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Table 1: Effect of D. cordata on 2,4-DNP-induced hyperthermia in rats.                 
Treatment Dose 
(mg kg-1) 
TO T0.5h T1h T2h T3h T4h 
Distilled water (10ml kg-1) 37.73±0.10 38.65±0.14 38.93±0.14 39.12±0.13 39.10±0.15 39.08±0.15 
D. cordata 100 37.80±0.14 38.77±0.15 38.48±0.15** 
(43.3%) 
38.23±0.14*** 
(69%) 
38.03±0.17*** 
(83%) 
37.93±0.23*** 
(90.6%) 
D. cordata 200 37.37±0.16 38.17±0.13 37.80±0.12*** 
(58.3%) 
37.68±0.14*** 
(79.9%) 
37.65±0.14*** 
(79.6%) 
37.47±0.18*** 
(95.7%) 
D. cordata 400 37.28±0.18 38.07±0.19 37.75±0.16*** 
(65%) 
37.50±0.14*** 
(84%) 
37.35±0.14*** 
(94.9%) 
37.22±0.17*** 
(104.3%) 
ASA 100 37.62±0.19 38.47±0.28 38.17±0.19*** 
(52.5%) 
37.93±0.19*** 
(77.7%) 
37.75±0.16*** 
(90.5%) 
37.52±0.19*** 
(107.2%) 
 
Values are mean ± SEM (n = 6). **p<0.01, ***p<0.001 vs. control (one way ANOVA followed by Tukey’s multiple comparison test) in respect of increase in temperature. Figures 
in parenthesis indicate inhibition (%) of temperature elevation.       
 
 
 
Table 2: Effect of D. cordata on amphetamine-induced hyperthermia in rats.      
Treatment 
 
Dose 
(mg/kg) 
TO T0.5h T1h 
 
T2h T3h T4h 
Distilled water (10ml/kg) 35.77±0.28 38.18±0.35 38.15±0.15 38±0.33 38.68±0.14 38.78±0.15 
D. cordata 100 36.67±0.34 37.75±0.36 38.78±0.40 
(11.3%) 
38.35±0.36*** 
(24.7%) 
37±0.31 
(88.7%) 
36.25±0.47*** 
(112.3%) 
D. cordata 200 36.62±0.35 38.07±0.39 37.17±0.51* 
(76.9%) 
36.62±0.50*** 
(100%) 
36.42±0.52* 
(122%) 
36.15±0.54*** 
(115.6%) 
D. cordata 400 36.50±0.31 38.43±0.75 37.78±0.31 
(44.1%) 
37.45±0.29*** 
(42.6%) 
36.88±0.40 
(86.9%) 
36.40±0.34*** 
(103.3%) 
ASA 100 36.35±0.32 37.58±0.39 38.67±0.53 
(2.52%) 
37.30±0.34*** 
(57.4%) 
36.73±0.39 
(86.9%) 
36.47±0.27*** 
(96%) 
 
Values are mean ± SEM (n = 6). *p<0.05, ***p<0.001 vs. control (one way ANOVA followed by Tukey’s multiple comparison test) in respect of increase in temperature. Figures 
in parenthesis indicate inhibition (%) of temperature elevation.        
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Table 3: Effect of D. cordata on yeast-induced hyperthermia in rats.          
Treatment 
 
Dose 
(mg kg-1) 
 
TO T19h T20h T21h T22h T23h 
Distilled 
water 
(10ml kg-1) 36.87±0.31 38.40±0.18 38.73±0.13 
 
39.03±0.10 38.88±0.11 39.12±0.15 
D. cordata 100 36.65±0.16 38.47±0.19 38.15±0.37 
(19.4%) 
 
38.07±0.26 
(34.3%) 
37.92±0.37 
(36.8%) 
37.72±0.49 
(52.4%) 
D. cordata 200 36.42±0.41 38.53±0.19 38.63±0.27 
(24.29%) 
 
38.48±0.26 
(4.6%) 
38.20±0.39 
(11.4%) 
37.87±0.30 
(35.6%) 
D. cordata 400 36.97±0.22 38.45±0.18 38.38±0.21 
(24.29%) 
 
37.98±0.33 
(53.2%) 
37.65±0.22 
(66.2%) 
37.33±0.14* 
(83.6%) 
ASA 100 36.58±0.07 37.83±0.37 37.45±0.34 
(53.2%) 
37.45±0.34 
(59.7%) 
36.83±0.16 
(87.6%) 
36.88±0.23* 
(86.7%) 
 
Values are mean ± SEM (n=6). *p<0.05 vs. control (one way ANOVA followed by Tukey’s multiple comparison test) in respect of increase in temperature. Figures in parenthesis 
indicate inhibition (%) of temperature elevation.             
 
 
Table 4: Effect of D. cordata on normal body temperature of rats.        
Treatment 
 
Dose 
(mg kg-1) 
TO T1h 
 
T2h T3h T4h 
Distilled 
water 
 
(10ml kg-1) 
 
 
38.23±0.10 37.68±0.09 37.68±0.16 37.53±0.18 37.48±0.19 
D. cordata 
 
100 
 
38.25±0.10 37.35±0.09 37.40±0.18 37.45±0.06 37.40±0.14 
D. cordata 200 37.95±0.19 36.85±0.13 36.75±0.31 36.80±0.28 36.85±0.31 
D. cordata 
 
 
400 
38.28±0.29 36.85±0.09* 36.75±0.18 36.73±0.17 36.68±0.11 
ASA 
 
100 
 
38.10±0.27 37±0.18 37.25±0.23 37.05±0.30 36.95±0.24 
 
Values are mean ± SEM (n = 6). *p<0.05 vs. control (one way ANOVA followed by Tukey’s multiple comparison test) in respect of increase in temperature.       
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The mouse writhing test is useful for the evaluation of mild analgesic non-steroidal anti-inflammatory compounds 
(Berkenkopf and Weichman, 1988; Nunez Guillen et al., 1997) and peripherally acting drugs like ASA have been reported to 
exhibit analgesic activity in the writhing test only (Zakaria et al., 2008). Writhings induced by chemical substances like acetic 
acid involves stimulation of the peripheral receptor system and is partly attributed to the local peritoneal receptors found at the 
surface of the cells lining the peritoneal cavity (Zakaria et al., 2008). Prolonged irritation of the peritoneal cavity by acetic acid 
results in increase in the levels of peritoneal fluid prostaglandins, like PGE2 and PGF2α, which enhances inflammatory pain by 
increasing capillary permeability (Vogel and Vogel, 1997; Zakaria et al., 2008). The analgesic effect demonstrated by D. cordata 
extract in the mouse writhing test in this study suggest a peripheral mechanism of action involving direct action on nociceptors, 
direct inhibition of prostaglandin action or indirect inhibition of prostaglandin synthesis by inhibition of cyclo-oxygenase (COX) 
activity. The effectiveness of D. cordata extract in this test indicates its potential usefulness in the treatment of acute pain as the 
abdominal constriction test is said to be indicative of acute pain (Cowan, 1990).  
However, effectiveness in the mouse writhing test is not specifically indicative of peripheral and/or central activity 
(Chan et al., 1995) as centrally acting drugs like morphine are also effective in the mouse writhing test as confirmed by the result 
obtained in this study. This formed the basis for the use of the formalin and tail clip tests. Further justification for the use of these 
methods is the fact that in addition to non-steroidal anti-inflammatory drugs, anti-histaminics and anti-cholinergics can inhibit the 
writhing response (Singh and Majumdar, 1995).   
  The formalin test produces distinct biphasic nociceptive response; an initial acute response (early phase) and a 
prolonged response (late phase; Malmberg and Yaksh, 1992), 0-5 min. and 15-30 min. respectively, as observed in this study. 
Injection of formalin causes immediate and intense increase in the spontaneous activity of afferent C fibers and evokes distinct 
quantifiable behavior indicative of pain (Zakaria et al., 2008); biting and licking of the injected paw as observed in this study. The 
early phase is due to direct effect of formalin on nociceptors while the late phase is a tonic response involving inflammatory 
processes and neurons in the dorsal horns of the spinal cord are activated (Tjolsen et al., 1992; Zakaria, 2008). Drugs which act 
mainly centrally, like narcotic analgesics e.g. morphine, inhibit both phases of the formalin test while peripherally acting drugs 
like ASA inhibit the late phase only (Santos et al., 1994; Chan et al., 1995). According to Cowan (1990), the formalin test can 
also be used to indicate the potential of analgesic agents to treat chronic pain due to inflammation. D. cordata extract in this study 
did not demonstrate effective analgesic activity in the first phase of the formalin test but was active in the second phase. In 
agreement with literature, morphine was effective in both phases of the formalin test while ASA was only effective in the second 
phase. Findings in the formalin test suggest that D. cordata extract acts through peripheral mechanism of action, as established in 
the mouse writhing test, demonstrating possible effectiveness in the treatment of chronic inflammatory pain by inhibition of 
associated inflammatory processes, basically release and/or action of inflammatory mediators. This assertion is supported by the 
report of Adeyemi et al. (2008) that D. cordata extract possess anti-inflammatory activity.  
  The tail clip test was used in this study to investigate the involvement of central mechanisms in the analgesic activity of 
D. cordata extract, as centrally acting analgesic drugs like morphine elevate the pain threshold of rodents towards heat and 
pressure (Singh and Majumdar, 1995). In the mouse writhing and formalin tests, D. cordata extract demonstrated analgesic 
activity at doses of 200 and 100 mg kg-1 body weight respectively at 90 min., considering the time of treatment with test and 
standard drugs and the observation period after pain induction. However, in the tail clip test D. cordata demonstrated analgesic 
activity at the highest dose of 400 mg kg-1 body weight at 180 min. post-treatment. This finding suggest that the mechanism of 
action of the analgesic effect of D. cordata extract shifts from peripheral to central mechanism with increasing dose and post-
treatment time.   
  Over the years, various approaches in terms of duration and time interval of counting of number of writhes in the mouse 
writhing test have been adopted. This has ranged from 15-30 min. as used by various researchers (Singh and Majumdar, 1995; 
Nunez Guillen et al., 1997; Akindele and Adeyemi, 2006; Zakaria et al., 2008). In this study, a consideration of the time course of 
acetic acid-induced mouse writhing shows that the greatest number of writhes was generally produced at the 5-10 min. time 
interval. We therefore suggest the adoption of the 5-10 min. interval in the counting of writhes in the mouse writhing test as a way 
of strengthening the rapidity of the model in the screening of agents for analgesic activity.             
 Fever is one of the most common signs of illness and it is best defined as an increase in temperature over what is 
normal for a given individual at that particular time of day (Wolff et al., 1975). The normal body temperature is regulated by a 
centre in the hypothalamus, which ensures a balance between heat loss and heat production. Fever occurs when there is a 
disturbance of this hypothalamic thermostat that leads to the set point of body temperature being raised (Rang et al., 1999). 
According to Uzcategui et al. (2004), pyretic activity involves stimulation of the region in the hypothalamus that controls body 
temperature via prostaglandins synthesized within the central nervous system (CNS) and antipyretic agents must access the brain 
through the blood-brain barrier (BBB) which prevents drug molecules and chemicals from entering the CNS (Begley et al., 2000).        
 In this study, D. cordata extract demonstrated effective antipyretic activity as evident in the results obtained in all the different 
experimental models of pyrexia. It inhibited temperature elevation in all the models employed. Its antipyretic effect may be due to 
the inhibition of prostaglandin synthesis in the hypothalamus because prostaglandins play an important role in the development of 
pain, inflammation and fever, especially since the extract had been shown to possess anti-inflammatory activity (Adeyemi et al., 
2008). The antipyretic activity demonstrated by D. cordata extract in this study provides a further justification for a central 
mechanism of analgesic action of the extract at the highest dose used as ability to cross the BBB is a possible factor contributing 
to antipyretic activity (Zakaria, 2008). The plant did not generally affect the normal body temperature since its significance was at 
1 h after administration but for d-amphetamine and 2,4-DNP models, its significance was at the 3rd and 4th hour which implies that 
it is not due to any hypothalamic effect. The behavioral observations made in rats in the amphetamine model such as increased 
Akindele et al.,  Afr J Tradit Complement Altern Med. (2012) 9(1):25‐35 
http://dx.doi.org/10.4314/ajtcam.v9i1.4 
34
alertness, aggressiveness and locomotor activity, stereotyped behavior (consisting of repeated actions like licking, gnawing and 
rearing) are due to the fact that amphetamine is a psychomotor (CNS) stimulant (Rang et al., 2003).   
  The aqueous whole plant extract of D. cordata was found in this study to contain glycosides, saponins, alkaloids, 
flavonoids, phenols, and tannins in increasing order of abundance. The extract was previously reported to contain these 
phytochemicals (Adeyemi et al., 2008).  One or a combination of this phytoconstituents may be responsible for the analgesic and 
antipyretic activities observed with D. cordata in this study, especially as synergy is an important concept in the pharmacology of 
phytochemicals of botanical medicines (Larkins and Wynn, 2004). Saponins (glycosides with the sugar moiety attached to the 
hydrophilic end) and related phytosterols have been associated with anti-inflammatory, antipyretic, and immune-modulating 
properties (Larkins and Wynn, 2004). Alkaloids which generally have wide pharmacological actions are analgesics and narcotics 
(Raaman, 2006) and their ability to cross the blood-brain barrier and interact with various neurotransmitter receptors determine 
much of their pharmacology (Larkins and Wynn, 2004). Some alkaloids have also been reported to possess anti-inflammatory 
activity (Larkins and Wynn, 2004). Phenols including flavonoids have been shown to possess various pharmacological and 
biochemical actions including antipyretic and anti-inflammatory properties (Larkins and Wynn, 2004). Specific flavonoids and 
related compounds e.g. genistein, kaempferol, quercetin, resorcinol, and resveratrol have been reported to exhibit cyclo-
oxygenase (COX)-2 inhibition activity and dose-dependent decreases in inflammatory-mediating cytokine TNFα (Mutoh et al., 
2000). However, according to Maekawa et al. (1999) plant-based COX-2 inhibitors, unlike pharmacologic nonsteroidal anti-
inflammatory drugs (NSAIDs), have a slow onset of pain relief. The abundance of tannins in the whole plant extract of D. cordata 
provides a justifaction for further pharmacological investigations as this class of phytochemicals have been associated with 
antisecretory, antibacterial, wound healing, antidiarrhea, and antioxidant activities (Larkins and Wynn, 2004).  
 In a previous study, Adeyemi et al. (2008) reported the safety of oral administration of the aqueous extract of D. 
cordata based on the fact that no mortality and visible signs of toxicity were recorded given up to 2 g kg-1. The LD50 administered 
intraperitoneally was estimated to be 133.35 mg kg-1.             
 
Conclusion          
 
The results obtained in this study demonstrate that the aqueous whole plant extract of Drymaria cordata possesses 
analgesic and antipyretic properties mediated through peripheral and central mechanisms. This finding justifies the use of the 
extract in traditional medicine for the treatment of painful and febrile conditions. A bioactivity guided fractionation of the extract 
will reveal the specific chemical agent(s) responsible for the observed effects of D. cordata and the exercise could also possibly 
throw up lead compound(s) for the development of newer, more efficacious and better tolerated drugs.       
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